GUIDANCE-10

AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL

Polatuzumab VedotinOngoingNot yet recruitingPhase 2Open NCT07594899 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…